Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

When warrants are converted, shares are issued. It is not possible to know what S&L did with those shares until the next filing. All that is known as a fact is that from the filed holding of 32,248,173 shares, PTSC are purchasing 7,000,000 warrants and 16,845,100 warrants have since been converted. This gives a maximum holding for S&L of 25,248,173* shares.

S&L's holdings would reduce if some of the warrants were used in the cashless conversion of other warrants and/or they sold. We do not know what they have done yet.

In theory, S&L could hold anything from 25,248,173* shares down to nil.

(* unless they've been buying, but only before the warrant repurchase was announced as they are precluded from buying as long as PTSC are purchasing the warrants).

 

 

Be well

Share
New Message
Please login to post a reply